MARKET

AKBLF

AKBLF

Alk-Abello A/S
OTCPK
31.35
NaN%
Opening 09:30 06/29 EDT
OPEN
--
PREV CLOSE
31.35
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
34.50
52 WEEK LOW
31.35
MARKET CAP
6.31B
P/E (TTM)
35.00
1D
5D
1M
3M
1Y
5Y
1D
EURneffy 1 mg approved in the UK as the first and only needle-free adrenaline treatment for young children (aged 4 and older, 15–30 kg) at risk of anaphylaxis
Barchart · 06/15 02:00
Anaphylaxis management is falling short in 2026 – EAACI data suggest EURneffy, the only needle-free nasal adrenaline spray, could help close the gap
Barchart · 06/11 02:00
ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026
Barchart · 06/04 01:30
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Barchart · 06/01 14:20
ALK to present at the Jefferies Global Healthcare Conference in New York
Barchart · 05/29 09:27
ALK-Abello initiated with a Buy at Berenberg
TipRanks · 05/27 08:28
ALK-Abelló Lifts Outlook After Strong Q1 Call
TipRanks · 05/06 00:43
ALK-Abelló A/S reports Q1 results, raises guidance
Seeking Alpha · 05/05 17:06
More
About AKBLF
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.

Webull offers ALK-Abello A/S stock information, including OTCPK: AKBLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKBLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKBLF stock methods without spending real money on the virtual paper trading platform.